Sorrento Therapeutics Inc. (SRNE): Price and Financial Metrics
SRNE Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.25 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 128,900 |
| Day high | $0.00 | Avg. volume | 274,978 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.01 | Market Cap | 1.49M |
SRNE Stock Price Chart Interactive Chart >
Sorrento Therapeutics Inc. (SRNE) Company Bio
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
SRNE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching SRNE
Want to do more research on Sorrento Therapeutics Inc's stock and its price? Try the links below:Sorrento Therapeutics Inc (SRNE) Stock Price | Nasdaq
Sorrento Therapeutics Inc (SRNE) Stock Quote, History and News - Yahoo Finance
Sorrento Therapeutics Inc (SRNE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...